Which statement about acute migraine treatment includes ergotamines?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Ergotamines are an older class of drugs used to stop an acute migraine attack by causing vasoconstriction of cranial blood vessels, countering the dilation that drives the pain. They are indeed part of acute treatment options, but their use is limited by safety concerns—most notably the risk of ergotism from excessive vasoconstriction, interactions with other vasoconstrictors or strong CYP3A4 inhibitors, and higher risks in people with cardiovascular disease, hypertension, liver or kidney impairment, or pregnancy. Because of these risks, they’re not first-line and are typically reserved for select patients who don’t respond to more preferred therapies like triptans or NSAIDs. They are not universally avoided, nor are they used only in pregnancy; in fact, they are contraindicated in pregnancy. This is why the statement that they are part of acute treatment options is correct.